Cobra venom factor stimulates anti-α-galactose antibody production in baboons: Implications for pig-to-human xenotransplantation

Transplantation

Volumn 62, Issue 5, 1996, Pages 678-681

  Taniguchi, S ^a   Kobayashi, T ^a   Neethling, F A ^a   Ye, Y ^a   Niekrasz, M ^b   White, D J G ^c   Cooper, D K C ^a,d  

^a INTEGRIS Nazih Zuhdi Transplant Institute   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CARBOHYDRATE ANTIGEN; COBROTOXIN; COMPLEMENT COMPONENT C3; GALACTOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BABOON; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG MECHANISM; GRAFT REJECTION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SWINE; XENOTRANSPLANTATION;

EID: 0029787895     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199609150-00024     Document Type: Article

References (15)

1. Cooper DKC, Ye Y, Rolf LL Jr, Zuhdi N. The pig as potential organ donor for man. In: Cooper DKC et al., eds. Xenotransplantation. Heidelberg: Springer, 1991: 481.
2. Good AH, Cooper DKC, Malcolm AJ, et al. Identification of carbohydrate structures that bind human anti-porcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559.
3. Cooper DKC, Good AH, Koren E, et al. Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transplant Immunol 1993; 1: 198.
4. Kujundzic M, Koren E, Neethling FA, et al. Variability of anti-αGal antibodies in human serum and their relation to serum cytotoxicity against pig cells. Xenotransplantation 1994; 1: 58.
5. Oriol R, Ye Y, Koren E, Cooper DKC. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ Xenotransplantation. Transplantation 1993; 56: 1433.
6. Platt JL, Bach FH. Mechanism of tissue injury in hyperacute xenograft rejection. In: Cooper DKC et al., eds. Xenotransplantation. Heidelberg: Springer, 1991: 69.
7. Cochrane CG, Muller-Eberhard HJ, Aikin BS. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J Immunol 1970; 105: 55.
8. Vogel C-W, Smith CA, Muller-Eberhard HJ. Cobra venom factor: structural homology with the third component of human complement. J Immunol 1984; 133: 3235.
9. Kobayashi T, Kemp E, Cooper DKC. Prolongation of discordant xenograft survival by cobra venom factor. In: Cooper DKC et al., eds. Xenotransplantation, 2nd ed. Heidelberg: Springer, in. press.
10. Kobayashi T, Taniguchi S, Ye Y, et al. Delayed xenograft rejection in 03-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor. Transplant Proc 1996; 28: 560.
11. Gowda DC, Schultz M, Bredehorst R, Vogel C-W. Structure of the major oligosaccharide of cobra venom factor. Mol Immunol 1992; 29: 335.
12. Harrison RA, Lachman PJ. Complement technology. In: Weir DM et al., eds. Handbook of experimental immunology, 4th ed. Oxford: Blackwell, 1986.
13. Koren E, Neethling FA, Koscec M, et al. In vitro model for hyperacute rejection of xenogeneic cells. Transplant Proc 1994; 26: 1166.
14. Cobbold SP, Rebello PRUB, Davies HS, et al. A simple method for measuring patient anti-globulin responses against isotypic or idiotypic determinants. J Immunol Methods 1990; 127: 19.
15. Gowda DC, Petrella EC, Raj TT, Bredehorst R, Vogel C-W. Immunoreactivity and function of oligosaccharides in cobra venom factor. J Immunol 1994; 152: 2977.